Ignite Creation Date:
2024-05-06 @ 10:44 AM
Last Modification Date:
2024-10-26 @ 12:34 PM
Study NCT ID:
NCT03338972
Status:
COMPLETED
Last Update Posted:
2023-09-08
First Post:
2017-11-07
Brief Title:
Immunotherapy With BCMA CAR-T Cells in Treating Patients With BCMA Positive Relapsed or Refractory Multiple Myeloma
Sponsor:
Fred Hutchinson Cancer Center
Organization:
Fred Hutchinson Cancer Center
Organization Data
Organization:
Fred Hutchinson Cancer Center
Class:
OTHER
Study ID:
9762
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Fred Hutchinson Cancer Center
Lead Sponsor Class:
OTHER
Responsible Party:
Damian Green
Responsible Party Title:
Associate Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Fred Hutchinson Cancer Center
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |
| Juno Therapeutics Inc a Bristol-Myers Squibb Company | INDUSTRY |